Niraparib + Dostarlimab + RT in Pancreatic Cancer
Conditions: Pancreatic Cancer; Metastatic Pancreatic Cancer Interventions: Drug: Niraparib; Drug: Dostarlimab; Radiation: Radiation Sponsors: Massachusetts General Hospital; Tesaro, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials